Illuminating RNA trafficking and functional delivery by extracellular vesicles
- PMID: 33894328
- DOI: 10.1016/j.addr.2021.04.017
Illuminating RNA trafficking and functional delivery by extracellular vesicles
Abstract
RNA-based therapeutics are highly promising for the treatment of numerous diseases, by their ability to tackle the genetic origin in multiple possible ways. RNA molecules are, however, incapable of crossing cell membranes, hence a safe and efficient delivery vehicle is pivotal. Extracellular vesicles (EVs) are endogenously derived nano-sized particles and possess several characteristics which make them excellent candidates as therapeutic RNA delivery agent. This includes the inherent capability to functionally transfer RNAs in a selective manner and an enhanced safety profile compared to synthetic particles. Nonetheless, the fundamental mechanisms underlying this selective inter- and intracellular trafficking and functional transfer of RNAs by EVs are poorly understood. Improving our understanding of these systems is a key element of working towards an EV-based or EV-mimicking system for the functional delivery of therapeutic RNA. In this review, state-of-the-art approaches to detect and visualize RNA in situ and in live cells are discussed, as well as strategies to assess functional RNA transfer, highlighting their potential in studying EV-RNA trafficking mechanisms.
Keywords: CRISPR/Cas; Exosomes; Extracellular vesicles; FISH; Fluorogenic aptamer; Live-cell imaging; MS2-system; Molecular beacon; RNA-based therapeutics.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [P.V. serves on the scientific advisory board of Evox Therapeutics].
Similar articles
-
Extracellular vesicles: The next generation in gene therapy delivery.Mol Ther. 2023 May 3;31(5):1225-1230. doi: 10.1016/j.ymthe.2023.01.021. Epub 2023 Jan 25. Mol Ther. 2023. PMID: 36698310 Free PMC article. Review.
-
A CRISPR-Cas9-based reporter system for single-cell detection of extracellular vesicle-mediated functional transfer of RNA.Nat Commun. 2020 Feb 28;11(1):1113. doi: 10.1038/s41467-020-14977-8. Nat Commun. 2020. PMID: 32111843 Free PMC article.
-
Natural or Synthetic RNA Delivery: A Stoichiometric Comparison of Extracellular Vesicles and Synthetic Nanoparticles.Nano Lett. 2021 Feb 24;21(4):1888-1895. doi: 10.1021/acs.nanolett.1c00094. Epub 2021 Feb 11. Nano Lett. 2021. PMID: 33570966 Free PMC article.
-
Promising RNA-based cancer gene therapy using extracellular vesicles for drug delivery.Expert Opin Biol Ther. 2020 Jul;20(7):767-777. doi: 10.1080/14712598.2020.1738377. Epub 2020 Mar 11. Expert Opin Biol Ther. 2020. PMID: 32125904 Review.
-
Integrin beta 1 and fibronectin mediate extracellular vesicle uptake and functional RNA delivery.J Biol Chem. 2025 Mar;301(3):108305. doi: 10.1016/j.jbc.2025.108305. Epub 2025 Feb 11. J Biol Chem. 2025. PMID: 39947471 Free PMC article.
Cited by
-
Simultaneous subset tracing and miRNA profiling of tumor-derived exosomes via dual-surface-protein orthogonal barcoding.Sci Adv. 2023 Oct 6;9(40):eadi1556. doi: 10.1126/sciadv.adi1556. Epub 2023 Oct 4. Sci Adv. 2023. PMID: 37792944 Free PMC article.
-
Adapter dimer contamination in sRNA-sequencing datasets predicts sequencing failure and batch effects and hampers extracellular vesicle-sRNA analysis.J Extracell Biol. 2023 Jun 11;2(6):e91. doi: 10.1002/jex2.91. eCollection 2023 Jun. J Extracell Biol. 2023. PMID: 38938917 Free PMC article.
-
Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease.Front Endocrinol (Lausanne). 2022 Sep 6;13:961802. doi: 10.3389/fendo.2022.961802. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36147580 Free PMC article. Review.
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.J Extracell Vesicles. 2024 Feb;13(2):e12404. doi: 10.1002/jev2.12404. J Extracell Vesicles. 2024. PMID: 38326288 Free PMC article.
-
CD7-targeting pro-apoptotic extracellular vesicles: A novel approach for T-cell haematological malignancy therapy.J Extracell Vesicles. 2024 Dec;13(12):e70025. doi: 10.1002/jev2.70025. J Extracell Vesicles. 2024. PMID: 39676736 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources